Research increasingly suggests that addiction has a genetic and neurobiological basis, but efforts to translate research into effective clinical treatments and social policy needs to be informed by careful ethical analyses of the personal and social implications. Scientists and policy makers alike must consider possible unintended negative consequences of neuroscience research so that the promise of reducing the burden and incidence of addiction can be fully realized and new advances translated into clinically meaningful and effective treatments.
This volume brings together leading addiction researchers and practitioners with neuroethicists and social scientists to specifically discuss the ethical, philosophical, legal and social implications of neuroscience research of addiction, as well as its translation into effective, economical and appropriate policy and treatments. Chapters explore the history of ideas about addiction, the neuroscience of drug use and addiction, prevention and treatment of addiction, the moral implications of addiction neuroscience, legal issues and human rights, research ethics, and public policy.
TABLE OF CONTENTS
¡What is addiction neuroethics and why does it matter?
¡Molecular Neuroscience and Genetics
¡Neuroimaging and Cognitive Neuroscience
¡Consent and Coercion
¡Opioid Substitution Treatment
¡Nicotine Replacement Therapy
¡New Approaches to Addiction Treatment: Vaccines, Sustained-release Medications, DBS
¡Personalized Treatment and Pharmacogenomics
¡Screening for High-risk Individuals: Phenotypes and Biomarkers
¡Public Health Approaches to Alcohol, Tobacco and Illicit Drugs
¡Autonomy and Responsibility
¡Identity and the Self
¡Legal Issues and Regulation
¡History of Ideas About Addiction and the Impact of Neuroscience
¡Neuroscience, Law and Addiction in the Media
¡The Future of Healthcare for Addicted Individuals
Edited by Adrian Carter, School of Psychological Science, University of Melbourne, Victoria, Australia; Wayne Hall, School of Population Health, University of Queensland, Herston, Australia and Judy Illes, Professor of Neurology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, CANADA